Scilife Pharma products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi-based branded-generic pharmaceutical manufacturer with a cGMP-focused manufacturing facility and multiple therapeutic business areas.
Scilife Pharma products in Pakistan
Scilife Pharma Private Limited has 232 medicine presentations registered in Pakistan under 60 brands, covering 55 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Endocrine & metabolic. Its brands with the most registered strengths and packs are Lochol (Atorvastatin), Sciampa-M (Empagliflozin + Metformin), Telysa-AM (Telmisartan + Amlodipine) and SciAmpa (Empagliflozin). 232 products have an official DRAP price on MedInfoBase. See all 60 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Scilife Pharma (Pvt.) Limited
- Company type
- Private pharmaceutical manufacturer
- Address
- FD-57/58-A2, Korangi Creek Industrial Park, Karachi-75190, Pakistan · 75190
- Website
- scilife.biz ↗
- Phone
- +92 21 111 724 543
- career@scilife.biz
- Official contact
- Contact page ↗
- Official company profile ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Scilife Pharma Private Limited is priced against the market
220 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Amstan 10/160 mg TabletRegistry verified | Amlodipine (as Amlodipine besylate), Valsartan | — | — | — | 082074Official source ↗ | No indexed price | — | — |
| Amstan 5/160 mg TabletRegistry verified | Amlodipine (as Amlodipine besylate), Valsartan | — | — | — | 082073Official source ↗ | No indexed price | — | — |
| Amstan 5/80 mg TabletRegistry verified | Amlodipine (as Amlodipine besylate), Valsartan | — | — | — | 082072Official source ↗ | No indexed price | — | — |
| B-Form | Budesonide + Formoterol | 100 mcg + 6 mcg | Inhalation capsule | 30's | 082189 | PKR 405.74 | PKR 13.52/capsule | 🔒 Pharma Pro |
| B-Form | Budesonide + Formoterol | 200 mcg + 6 mcg | Inhalation capsule | 30's | 082190 | PKR 568.43 | PKR 18.95/capsule | 🔒 Pharma Pro |
| B-Form DS | Budesonide + Formoterol | 400 mcg + 12 mcg | Inhalation capsule | 30's | 103090 | PKR 738.63 | PKR 24.62/capsule | 🔒 Pharma Pro |
| Cee-In | Ascorbic acid | 500 mg | Chewable tablet | 40's | 105210 | PKR 48.72 | PKR 1.22/tablet | 🔒 Pharma Pro |
| Chlorgel | Chlorhexidine gluconate | 7.1 % | Gel | 5gm | 100190 | PKR 42.21 | PKR 8.44/g | 🔒 Pharma Pro |
| Chlorgel | Chlorhexidine gluconate | 7.1% w/w (equiv. 4% chlorhexidine) | Gel | 15gm | 100190 | PKR 123.24 | PKR 8.22/g | No comparator |
| Chlorgel | Chlorhexidine gluconate | 7.1 % | Gel | 10gm | 100190 | PKR 82.73 | PKR 8.27/g | 🔒 Pharma Pro |
| Chloroquine | Chloroquine | 250 mg | Tablet | 500's | 105211 | PKR 626.92 | PKR 1.25/tablet | 🔒 Pharma Pro |
| Claxy | Clarithromycin | 500 mg | Extended-release tablet | 5's | 089119 | PKR 426.32 | PKR 85.26/tablet | 🔒 Pharma Pro |
| Claxy | Clarithromycin | 250 mg | Tablet | 10's | 089183 | PKR 478.74 | PKR 47.87/tablet | 🔒 Pharma Pro |
| Claxy | Clarithromycin | 500 mg | Tablet | 10's | 089184 | PKR 797.89 | PKR 79.79/tablet | 🔒 Pharma Pro |
| Claxy | Clarithromycin | 250 mg/5 mL | Suspension | 60ml | 100989 | PKR 749.33 | PKR 12.49/mL | 🔒 Pharma Pro |
| Claxy | Clarithromycin | 125 mg/5 mL | Suspension | 60ml | 100990 | PKR 454.08 | PKR 7.57/mL | 🔒 Pharma Pro |
| Co-Trupril | Lisinopril | 20 mg | Tablet | 28's | 088237 | PKR 946.20 | PKR 33.79/tablet | 🔒 Pharma Pro |
| Co-Trupril | Lisinopril | 20 mg | Tablet | 14's | 088237 | PKR 416.20 | PKR 29.73/tablet | 🔒 Pharma Pro |
| Daclife | Daclatasvir | 60 mg | Tablet | 28's | 086634 | PKR 9,080.04 | PKR 324.29/tablet | 🔒 Pharma Pro |
| Dydrotab Tablet 10mgRegistry verified | Dydrogesterone | — | — | — | 134875Official source ↗ | No indexed price | — | — |
| Foxatin | Fluoxetine | 20 mg | Capsule | 10's | 090860 | PKR 129.66 | PKR 12.97/capsule | 🔒 Pharma Pro |
| Hyclozol CreamRegistry verified | Clotrimazole, Hydrocortisone | — | — | — | 083085Official source ↗ | No indexed price | — | — |
| Hydra | Sodium chloride | 13.50 g | Sachet | 20's | 083000 | PKR 437.96 | PKR 21.90/sachet | No comparator |
| Hydroxychloroquine | Hydroxychloroquine | 200 mg | Tablet | 50's | 101281 | PKR 680.20 | PKR 13.60/tablet | 🔒 Pharma Pro |
| Hydroxychloroquine | Hydroxychloroquine | 200 mg | Tablet | 30's | 101281 | PKR 408.12 | PKR 13.60/tablet | 🔒 Pharma Pro |
| Inspryn | Acetylsalicylic acid (Aspirin) | 81 mg | Tablet | 30's | 100436 | PKR 54.74 | PKR 1.82/tablet | 🔒 Pharma Pro |
| Lepsira | Levetiracetam | 250 mg | Tablet | 30's | 100437 | PKR 1,807.98 | PKR 60.27/tablet | 🔒 Pharma Pro |
| Lepsira | Levetiracetam | 250 mg | Tablet | 10's | 100437 | PKR 601.89 | PKR 60.19/tablet | 🔒 Pharma Pro |
| Lepsira | Levetiracetam | 500 mg | Tablet | 30's | 100438 | PKR 2,997.98 | PKR 99.93/tablet | 🔒 Pharma Pro |
| Lepsira | Levetiracetam | 500 mg | Tablet | 10's | 100438 | PKR 999.33 | PKR 99.93/tablet | 🔒 Pharma Pro |
| Lepsira | Levetiracetam | 750 mg | Tablet | 30's | 100439 | PKR 3,997.31 | PKR 133.24/tablet | 🔒 Pharma Pro |
| Lepsira | Levetiracetam | 750 mg | Tablet | 10's | 100439 | PKR 1,332.44 | PKR 133.24/tablet | 🔒 Pharma Pro |
| Lepsira XR | Levetiracetam | 500 mg | Extended-release tablet | 10's | 100440 | PKR 1,006.64 | PKR 100.66/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 10 mg | Tablet | 30's | 086601 | PKR 803.04 | PKR 26.77/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 10 mg | Tablet | 10's | 086601 | PKR 273.29 | PKR 27.33/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 10 mg | Tablet | 100's | 086601 | PKR 2,678.21 | PKR 26.78/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 10 mg | Tablet | 15's | 086601 | PKR 341.87 | PKR 22.79/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 10 mg | Tablet | 150's | 086601 | PKR 3,613.61 | PKR 24.09/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 20 mg | Tablet | 30's | 086602 | PKR 1,360.13 | PKR 45.34/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 20 mg | Tablet | 10's | 086602 | PKR 462.49 | PKR 46.25/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 20 mg | Tablet | 100's | 086602 | PKR 4,532.36 | PKR 45.32/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 20 mg | Tablet | 15's | 086602 | PKR 637.03 | PKR 42.47/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 20 mg | Tablet | 150's | 086602 | PKR 6,115.45 | PKR 40.77/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 20 mg | Tablet | 1500 | 086602 | PKR 61,155.34 | PKR 40.77/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 40 mg | Tablet | 30's | 086603 | PKR 2,255.67 | PKR 75.19/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 40 mg | Tablet | 10's | 086603 | PKR 767.31 | PKR 76.73/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 40 mg | Tablet | 100's | 086603 | PKR 7,519.59 | PKR 75.20/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 40 mg | Tablet | 15's | 086603 | PKR 1,056.89 | PKR 70.46/tablet | 🔒 Pharma Pro |
| Lochol | Atorvastatin | 40 mg | Tablet | 150's | 086603 | PKR 10,146.19 | PKR 67.64/tablet | 🔒 Pharma Pro |
| Lomisec | Omeprazole | 20 mg | Capsule | 14's | 082095 | PKR 293.22 | PKR 20.94/capsule | 🔒 Pharma Pro |
All 60 Scilife Pharma brands in Pakistan
- B-Form Budesonide + Formoterol · 100 mcg + 6 mcg inhalation, 200 mcg + 6 mcg inhalation
- B-Form DS Budesonide + Formoterol · 400 mcg + 12 mcg inhalation
- Cee-In Ascorbic acid · 500 mg tablet
- Chlorgel Chlorhexidine gluconate · 7.1 % gel, 7.1% w/w (equiv. 4% chlorhexidine) gel
- Chloroquine Chloroquine · 250 mg tablet
- Claxy Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
- Co-Trupril Lisinopril · 20 mg tablet
- Daclife Daclatasvir · 60 mg tablet
- Foxatin Fluoxetine · 20 mg capsule
- Hydra Sodium chloride · 13.50 g sachet
- Hydroxychloroquine Hydroxychloroquine · 200 mg tablet
- Inspryn Acetylsalicylic acid (Aspirin) · 81 mg tablet
- Lepsira Levetiracetam · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Lepsira XR Levetiracetam · 500 mg tablet
- Lochol Atorvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
- Lomisec Omeprazole enteric coated pellets, Omeprazole · 20 mg capsule, 40 mg injection, 40 mg capsule
- Lomisec Insta Omeprazole + Sodium bicarbonate, Omeprazole · 1680 mg + 1680 mg sachet, 20 mg sachet, 40 mg + 1680 mg sachet
- Losmart Losartan · 25 mg tablet, 50 mg tablet
- M-Low Amlodipine · 10 mg tablet, 5 mg tablet
- Maz-Pac Carbamazepine · 200 mg tablet
- MF Metformin · 1 g tablet, 250 mg tablet, 500 mg tablet
- Mupira Mupirocin · 2% ointment
- Nasdro Ondansetron · 8 mg tablet
- Norplat Clopidogrel, Clopidogrel + Aspirin · 300 mg tablet, 75 mg tablet, 75 mg + 75 mg tablet
- Norplat-S Clopidogrel + Aspirin · 75 mg + 75 mg tablet
- Olpavir Oseltamivir · 75 mg capsule
- Orpic Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Q-Lip Levofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Quti-lif Quetiapine · 25 mg tablet
- Quti-lif " Quetiapine · 100 mg tablet, 25 mg tablet
- Rihap Ribavirin · 400 mg tablet, 500 mg tablet, 600 mg tablet
- Rinalovir Lopinavir + Ritonavir · 100 mg + 25 mg tablet, 200 mg + 50 mg tablet
- RXN Rivaroxaban · 10 mg tablet, 15 mg tablet, 2.5 mg tablet
- Salbree Salbutamol · 200 mcg capsule
- Sci-Bislo Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
- Sci-D Cholecalciferol · 5 mg injection
- Sci-per Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- SciAmpa Empagliflozin · 10 mg tablet, 25 mg tablet
- Sciampa-M Empagliflozin + Metformin · 12.5 mg + 1000 mg tablet, 12.5 mg + 500 mg tablet, 5 mg + 1000 mg tablet
- Scicon MR Gliclazide · 30 mg tablet, 60 mg tablet
- Scifect Ceftriaxone · 1000 mg injection, 250 mg injection, 500 mg injection
- Scifix Cefixime · 100 mg/5 mL suspension, 200 mg tablet, 400 mg capsule
- Scifix DS Cefixime · 200 mg/5 mL suspension
- Scifovir Tenofovir disoproxil · 300 mg tablet
- Scihop Sofosbuvir · 400 mg tablet
- Scimether Artemether + Lumefantrine · 15 mg + 90 mg/5 mL suspension
- Scimox Moxifloxacin · 400 mg tablet, 400 mg infusion
- Scinoxa Enoxaparin · 4000 IU injection, 6000 IU injection
- Scipenem Meropenem · 1 g injection, 500 mg injection
- Scipram Escitalopram · 10 mg tablet, 20 mg tablet, 5 mg tablet
- Sowaita Sofosbuvir · 400 mg tablet
- Telysa-AM Telmisartan + Amlodipine · 10 mg + 40 mg tablet, 10 mg + 80 mg tablet, 40 mg + 10 mg tablet
- Telysa-H Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet, 80 mg + 25 mg tablet
- Teno-Alfa Tenofovir disoproxil, Tenofovir alafenamide · 25 mg tablet
- Trezo Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Twinvir Sofosbuvir · 400 mg tablet
- Tyo Tiotropium · 18 mcg inhalation
- Tyo Rotacaps Tiotropium · 18 mcg capsule, 18 mcg inhalation
- Valp-Sci Valproic acid, Divalproex sodium · 250 mg tablet, 269.10 mg tablet, 500 mg valproic acid equivalent (538.2 mg semisodium valproate) tablet
- Voxylid Linezolid · 100 mg/5 mL suspension, 400 mg tablet, 600 mg tablet
Scilife Pharma: common questions
How many products does Scilife Pharma have in Pakistan?
Scilife Pharma Private Limited has 232 registered medicine presentations in Pakistan, sold under 60 brands and covering 55 generic medicines.
What are the main brands of Scilife Pharma?
By number of registered strengths and packs, its largest brands are Lochol (Atorvastatin), Sciampa-M (Empagliflozin + Metformin), Telysa-AM (Telmisartan + Amlodipine), SciAmpa (Empagliflozin) and Trezo (Azithromycin). This is not a sales ranking.
Which therapy areas does Scilife Pharma cover?
The most products are in Anti-infectives (70), Cardiovascular (52), Endocrine & metabolic (36), CNS & mental health (27) and Hematology & thrombosis (21).
Where can I see Scilife Pharma medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.